Baliopharm
2011
FOUNDED
M&A
STATUS
M&A
LATEST DEAL TYPE
1
FINANCING ROUNDS
1
INVESTMENTS
Description
Developer of biotechnological therapeutic drugs in Basel, Switzerland. The company's products include therapeutics for the treatment of autoimmune diseases like rheumatoid arthritis, Crohn's disease, psoriasis and multiple sclerosis, enabling physicians and doctors to enhance their treatment procedures.
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Parent Company
Primary Office
- Stänzlergasse 4
- 4051 Basel
- Switzerland
+41 061 000 00 00
Baliopharm Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Baliopharm‘s full profile, request access.
Request full access to PitchBookBaliopharm Competitors (21)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Santhera Pharmaceuticals | Formerly VC-backed | Pratteln, Switzerland | 000 | 00000 | 0000 | 00000 |
| 0000000 | Accelerator/Incubator Backed | Wilmington, DE | 00.00 | 0000000000 | ||
| 0000 00000000000 | Venture Capital-Backed | Cambridge, MA | 00 | 00000 | 00000000000 | 00000 |
| 00000000 | Formerly VC-backed | South San Francisco, CA | 00 | 00000 | 0000000000. | |
| 0000000 0000000000 | Venture Capital-Backed | Diepenbeek, Belgium | 0 | 000.00 | 00000000000 | 000.00 |
Baliopharm Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00 000000000000000 | 05-Jul-2016 | 0000 00000 | 00000 | Drug Discovery |